FDA Inspection
Shanghai Henlius Biopharmaceuticals Co., Ltd.Shanghai Henlius Biopharmaceuticals Co., Ltd. – FDA Inspection, May 20, 2026
Record Details
This FDA Inspection record concerns Shanghai Henlius Biopharmaceuticals Co., Ltd., with an inspection on May 20, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- May 20, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 897c6bac-c4f8-4192-89cf-07119b106305
Inspection Facts
- Inspection number
- 1320008
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shanghai Henlius Biopharmaceuticals Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2023 | Not classified | Office of Inspections and Investigations | |
| August 18, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shanghai Henlius Biopharmaceuticals Co., Ltd.
- FDA Inspection 1222653 - 2023-10-27
- FDA Inspection 1256189 - 2023-08-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.